98%
921
2 minutes
20
Background: An emerging standard-of-care for long-QT syndrome uses clinical genetic testing to identify genetic variants of the KCNQ1 potassium channel. However, interpreting results from genetic testing is confounded by the presence of variants of unknown significance for which there is inadequate evidence of pathogenicity.
Methods And Results: In this study, we curated from the literature a high-quality set of 107 functionally characterized KCNQ1 variants. Based on this data set, we completed a detailed quantitative analysis on the sequence conservation patterns of subdomains of KCNQ1 and the distribution of pathogenic variants therein. We found that conserved subdomains generally are critical for channel function and are enriched with dysfunctional variants. Using this experimentally validated data set, we trained a neural network, designated Q1VarPred, specifically for predicting the functional impact of KCNQ1 variants of unknown significance. The estimated predictive performance of Q1VarPred in terms of Matthew's correlation coefficient and area under the receiver operating characteristic curve were 0.581 and 0.884, respectively, superior to the performance of 8 previous methods tested in parallel. Q1VarPred is publicly available as a web server at http://meilerlab.org/q1varpred.
Conclusions: Although a plethora of tools are available for making pathogenicity predictions over a genome-wide scale, previous tools fail to perform in a robust manner when applied to KCNQ1. The contrasting and favorable results for Q1VarPred suggest a promising approach, where a machine-learning algorithm is tailored to a specific protein target and trained with a functionally validated data set to calibrate informatics tools.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679743 | PMC |
http://dx.doi.org/10.1161/CIRCGENETICS.117.001754 | DOI Listing |
Cardiol Res Pract
August 2025
Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
Long QT syndrome (LQTS) is an inherited cardiac channelopathy marked by QT interval prolongation and increased risk of life-threatening arrhythmias. While variants in , , and explain most cases, many remain genetically unexplained. This study emphasizes the value of genetic testing in diagnosis and individualized therapy.
View Article and Find Full Text PDFBrain Dev
August 2025
Department of Pediatrics Neurology, Umraniye Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Background: Epilepsy, a neurological disease characterized by recurrent seizures, is highly heterogeneous in nature. The objective is to demonstrate that epilepsy is a complex neurodisorder influenced by multiple gene mutations and to advance genetic therapies through the discovery of novel variants.
Methods: In our study, 89 people with epilepsy of unknown cause were examined using the Sophia DDM® data analysis platform.
JACC Case Rep
August 2025
Department of Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, USA. Electronic address:
Acute myopericarditis in patients with pathogenic desmoplakin (DSP) variants are associated with a high risk for heart failure and cardiac arrhythmias. We present the case of a 25-year-old woman who presented with recurrent myopericarditis with chest pain and elevated troponin I levels despite escalating prednisone therapy. Genetic testing revealed a pathogenic variant in DSP along with a pathogenic variant in KCNQ1 associated with long-QT syndrome and a NOD2 variant associated with an increased risk for Crohn disease.
View Article and Find Full Text PDFInt J Mol Sci
July 2025
Sechenov Institute of Evolutionary Physiology & Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.
Voltage-gated potassium channels Kv7.1, encoded by the gene , play critical roles in various physiological processes. In cardiomyocytes, the complex Kv7.
View Article and Find Full Text PDFStem Cell Res
September 2025
University of California, San Diego, Institute for Genomic Medicine, La Jolla, CA, USA; University of California, San Diego, Department of Pediatrics, La Jolla, CA, USA. Electronic address:
Long QT syndrome (LQTS) is an inherited channelopathy characterized by life-threatening arrhythmias. LQTS has many subtypes defined by the gene that contains the mutation, including LQT1 (KCNQ1), LQT2 (KCNH2), and LQT3 (SCN5A). Here, we used CRISPR/Cas9 technology to generate five isogenic human induced pluripotent stem cell (iPSC) lines, one line harboring an LQT1 variant rs120074178 (KCNQ1 c.
View Article and Find Full Text PDF